Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Alpha Tau Medical LTD. clinical trials
The registry lists 29 studies whose lead sponsor is Alpha Tau Medical LTD.. 18 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 27, 2026.
Keep track of what changes. Save the Alpha Tau Medical LTD. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Alpha Tau Medical LTD..
- Alpha Tau Medical LTD.29 studiesSame company
Something wrong?
Focus areas
Conditions Alpha Tau Medical LTD. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 29 of 29.
- Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic CancerRecruitingNCT06698458Not applicable
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent GlioblastomaRecruitingNCT06910306Not applicable
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised PatientsRecruitingNCT06615635Not applicable
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic CancerRecruitingNCT06755359Not applicable
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Liver MetastasesRecruitingNCT05829291Not applicable
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue NeoplasiaRecruitingNCT04534127Not applicable
- Alpha Radiation Emitters Device (DaRT) for Target Treatments of Malignant TumorsRecruitingNCT05781555Not applicable
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Non-Metastatic Locally Recurrent Prostate Cancer.RecruitingNCT06202248Not applicable
- Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer (Feasibility and Safety)RecruitingNCT05657743Not applicable
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Lung CancerRecruitingNCT05632913Not applicable
- Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous TumorsRecruitingNCT04068155Not applicable
- Alpha Radiation Emitters for the Treatment of Pancreatic Cancer for the Treatment of Locally Advanced Pancreatic CancerRecruitingNCT06026943Not applicable
- Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCCRecruitingNCT05047094Not applicable
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Recurrent Prostate CancerNot yet recruitingNCT07290998Not applicable
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.RecruitingNCT03889899Not applicable
- A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.RecruitingNCT06202118Not applicable
- Neoadjuvant DaRT for Locally Advanced Oral Cavity SCCNot yet recruitingNCT05065346Not applicable
- Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT).Not yet recruitingNCT06202339Not applicable
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Cutaneous Squamous Cell CarcinomaActive, not recruitingNCT05323253Not applicable
- Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)Active, not recruitingNCT03737734Not applicable
- Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)TerminatedNCT03886181Not applicable
- Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic CancerActive, not recruitingNCT04002479Not applicable
- Retreatment With Intratumoral Diffusing Alpha Radiation EmittersCompletedNCT04540588Not applicable
- Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate CancerCompletedNCT04543903Not applicable
- Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant MetastasesTerminatedNCT03970967Not applicable
- Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue TumorsCompletedNCT04377360Not applicable
- A Retrospective Analysis to Evaluate Long Term Outcomes of SCC Patients Previously Treated With Alpha DaRTCompletedNCT05125354
- Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT)CompletedNCT03353077Not applicable
- Alpha Radiation Emitters Device for the Treatment of Squamous Cell CarcinomaCompletedNCT03015883Not applicable